Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis-Reference-Cited by-同舟云学术

Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis

Published:2004-11 Issue:10 Volume:34 Page:877-881
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Saccardi R,Tyndall A,Coghlan G,Denton C,Edan G,Emdin M,Farge D,Fassas A,Finke J,Furst D,Lassus M,Mancardi G,Miniati I,Mini E,Pagliai F,Passweg J,Pignone A,van Laar J M,Bocelli-Tyndall C,Matucci-Cerinic M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704656.pdf

Reference32 articles.

1. Van Laar JM, Tyndall A . Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control 2003; 10: 57–65.

2. Coghlan JG, Mukerjee D . The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol 2001; 13: 495–499.

3. Di Bello V, Ferri C, Giorgi D et al. Ultrasonic videodensitometric analysis in scleroderma heart disease. Coronary Artery Dis 1999; 10: 103–110.

4. Edan G, Miller D, Clanet M et al. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 1997; 62: 112–118.

5. Hartung HP, Gonsette R, Konig N et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 2002; 360: 2018–2025.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autogreffe de cellules souches périphériques dans la sclérodermie systémique : un progrès important, mais il faut tempérer notre enthousiasme !;La Revue de Médecine Interne;2024-02

2. WITHDRAWN: Autogreffe de cellules souches périphériques dans la sclérodermie systémique : un progrès important, mais il faut tempérer notre enthousiasme !;La Revue de Médecine Interne;2023-12

3. Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis;Journal of Scleroderma and Related Disorders;2023-02-07

4. Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease;Cells;2022-03-01

5. Hematopoietic stem cell transplantation in systemic sclerosis: Yes!! BUT. . .;Journal of Scleroderma and Related Disorders;2020-11-18